Can venetoclax/venetoclax cure leukemia?

Venetoclax is a drug used to treat certain types of leukemia, but it is not guaranteed to cure leukemia. Its effectiveness in treating leukemia depends on many factors, including the patient's specific condition, the severity of the disease and whether it is used in combination with other treatments. Treatment of leukemia usually requires a combination of multiple treatments, such as chemotherapy, radiotherapy, stem cell transplantation, etc.

Venetoclax is often used as part of a chemotherapy regimen to help control the progression of leukemia and improve patient survival. It can reduce the burden of leukemia by inhibiting the growth and spread of cancer cells. However, venetoclax may not completely eliminate all cancer cells, especially in more advanced stages of the disease. Regarding safety, the side effects of venetoclax are considered acceptable. Although there is a risk of tumor lysis syndrome (a complication that occurs when cancer cells are destroyed too quickly), this risk can be managed with preventive measures, such as gradually increasing or decreasing the dose when needed.

The original drug of Venekra has been launched in China and has been included in Class B medical insurance. The price of 100mg*14 tablets per box may be around 2,000 RMB, while the Turkish version of the original drug sold overseas, with the specification of 100mg*112 tablets, costs more than 10,000 RMB per box (the price may fluctuate due to the exchange rate). There are also cheaper generic drugs of Venacla sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 100mg*120 tablets produced by a Bangladesh pharmaceutical factory is more than 4,000 yuan per box (the price may fluctuate due to the exchange rate).